Peregrine's cancer drug data disappoints; shares plunge

(Reuters) - Peregrine Pharmaceuticals said an independent assessment of data from a mid-stage trial showed unexpectedly high progression-free survival rates in lung cancer patients receiving...

self storage dallas il villagio jacksonville fl go minis